Insulin and C-peptide response in healthy persons and individuals with impaired glucose metabolism during oral glucose tolerance test

Jugoslovenska Medicinska Biohemija

Volumn 24, Issue 1, 2005, Pages 35-39

  Nedić, Olgica ^a,b   Miloradović, Jasminka ^a,b   Ratković, Marija ^a,b   Masnikosa, Romana ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Inst for the Appl of Nucl Energy   (Serbia)

Author keywords

C peptide; Insulin; OGTT

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RADIOIMMUNOASSAY;

EID: 13244259383     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0501035N     Document Type: Article

References (16)

1. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER. eds. Tietz Textbook of Clinical Chemistry. Philadelphia: Saunders Company, 1994: 928-1001.
2. Majkić-Singh N. Instructions and recommendations for use of the laboratory methods in diabetes mellitus diagnosis and monitoring. Jugoslov Med Biohem 2003; 22 (Suppl 1): 1-4.
3. Cohen MP. Intervention strategies to prevent pathogenic effect of glycated albumin. Arch Biochem Biophys 2003; 419: 25-30.
4. Podwall D, Gooch C. Diabetic neuropathy: clinical features, etiology and therapy. Curr Neurol Neurosci Rep 2004; 4: 55-61.
5. Khamaisi M, Wexler ID, Skrha J, Strojek K, Raz I, Milicevic Z. Cardiovascular disease in type 2 diabetes: epidemiology, risk factors and therapeutic modalities. Isr Med Assoc J 2003; 5: 801-6.
6. Jerums G, Panagiotopoulos S, Forbes J, Osticka T, Cooper M. Evolving concepts in advanced glycation, diabetic nephropathy and diabetic vascular disease. Arch Biochem Biophys 2003; 419: 55-62.
7. Zamlakar M, Bajović Lj, Stefanović M. Definicija, dijagnoza i podela dijabetesa. In: Nacionalni vodič kliničke prakse, diabetes mellitus. Ministarstvo zdravlja Republike Srbije, 2002: 3-10.
8. Painter PC, Cope JY, Smith JL. Appendix - Reference Intervals. In: Burtis CA, Ashwood ER. eds. Tietz Textbook of Clinical Chemistry. Philadelphia: Saunders Company, 1994:2161-217.
9. Slijepčević D, Vujović S, Nestorović Z. Humana klinička endokrinologija. Beograd: Obeleija, 2002: 829-901.
10. Pirola L, Johnson AM, Van Obberghen E. Modulators of insulin action and their role in insulin resistance. Int J Obes Relat Metab Disord 2003; 27 (Suppl 3): 61-4.
11. Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately asses beta cell function in clinical studies. Eur J Endocrinol 2004; 150: 97-104.
12. Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003; 61: 397-412.
13. Eisenbarth GS. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes. Ann N Y Acad Sci 2003; 1005: 109-18.
14. Yamasaki H, Yamaguchi Y, Fujita N, Kato C, Kuwahara H, Yamauchi MD et al. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Acta Diabetol 2000; 37: 189-96.
15. Luyckx FH, Scheen AJ. How I exploreÿ the controversy concerning the role of oral glucose tolerance test in clinical practice. Rev Med Liege 2003; 58: 701-5.
16. Ignjatović S. Diagnosis of diabetes mellitus. Jugoslov Med Biohem 2003; 22 (Suppl 1): 13-19.